Two new iron(III) complexes of the formulas [Fe(bpm)Cl 3 (H 2 O)]·H 2 O ( 1 ) and [Fe 2 (bpm)Cl 6 (H 2 O) 2 ]·2H 2 O ( 2 ) (bpm = 2,2‘-bipyrimidine) have been synthesized and their crystal structures determined by single-crystal X-ray diffraction. 1 and 2 crystallize in the monoclinic system, space group P 2 1 / n, with a = 8.593(2) Å, b = 17.669(4) Å, c = 8.928(2) Å, β = 102.36(2)°, and Z = 4 for 1 and a = 6.422(3) Å, b = 11.999(4) Å, c = 12.297(6) Å, β = 93.82(4)°, and Z = 2 for 2 . The structure of complex 1 is made up of neutral [Fe(bpm)Cl 3 (H 2 O)] mononuclear units and water molecules of crystallization. The monuclear units are linked through hydrogen bonds involving the coordinated water molecule and one of the chlorine atoms yielding a uniform chain. The iron(III) is hexacoordinate, with two nitrogens of a chelating bpm, three chlorine atoms, and one water molecule building a distorted octahedron around the metal atom. The structure of 2 consists of centrosymmetric bpm-bridged dinuclear [Fe 2 (bpm)(Cl 6 )(H 2 O) 2 ] units and water molecules of crystallization which are linked through hydrogen bonds leading to a three-dimensional network. The geometry of each metal atom in 2 is distorted octahedral as in 1 . The equatorial positions around the metal ion in 1 and 2 are filled by two bpm nitrogens and two chlorine atoms, whereas the axial positions are occupied by a water molecule and a chlorine atom. The shortest intermolecular metal−metal distance in 1 is 5.957(2) Å, and the intramolecular metal−metal separation in 2 is 5.952(1). The magnetic behavior of 1 and 2 has been investigated over the temperature range 1.8−300 K. Significant antiferromagnetic coupling is observed for both compounds, the susceptibility curves exhibiting maxima at 5.0 ( 1 ) and 5.2 K ( 2 ). The pathways of the exchange interaction in 1 (hydrogen bonding) and 2 (hydrogen bonding and bridging bpm) are discussed in the light of their crystal structures, and the values of the coupling constants are compared with those of related systems.
No takes yet. Share an insight, caveat, or question.
Munno et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: